A detailed history of Fifth Third Bancorp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 9,462 shares of IONS stock, worth $379,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,462
Previous 9,633 1.78%
Holding current value
$379,047
Previous $417,000 7.91%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$36.45 - $47.7 $6,232 - $8,156
-171 Reduced 1.78%
9,462 $450,000
Q1 2024

Apr 23, 2024

BUY
$42.03 - $53.55 $14,752 - $18,796
351 Added 3.78%
9,633 $417,000
Q4 2023

Jan 19, 2024

BUY
$43.39 - $51.63 $294,270 - $350,154
6,782 Added 271.28%
9,282 $469,000
Q2 2023

Jul 25, 2023

SELL
$34.73 - $43.33 $17,365 - $21,665
-500 Reduced 16.67%
2,500 $102,000
Q1 2023

Apr 24, 2023

BUY
$33.58 - $41.2 $16,790 - $20,600
500 Added 20.0%
3,000 $107,000
Q2 2022

Aug 04, 2022

SELL
$31.71 - $43.0 $6,785 - $9,202
-214 Reduced 7.89%
2,500 $93,000
Q1 2022

Apr 19, 2022

BUY
$29.88 - $37.04 $2,629 - $3,259
88 Added 3.35%
2,714 $101,000
Q3 2021

Oct 15, 2021

BUY
$33.54 - $40.55 $2,414 - $2,919
72 Added 2.82%
2,626 $88,000
Q2 2021

Aug 06, 2021

SELL
$34.54 - $47.25 $241,918 - $330,939
-7,004 Reduced 73.28%
2,554 $102,000
Q1 2021

May 07, 2021

SELL
$42.51 - $63.78 $4,251 - $6,378
-100 Reduced 1.04%
9,558 $430,000
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $63,601 - $84,619
-1,404 Reduced 12.69%
9,658 $546,000
Q3 2020

Nov 09, 2020

SELL
$47.45 - $62.95 $5,978 - $7,931
-126 Reduced 1.13%
11,062 $525,000
Q1 2020

May 05, 2020

BUY
$41.6 - $63.4 $33,529 - $51,100
806 Added 7.76%
11,188 $529,000
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $166,935 - $202,337
3,100 Added 42.57%
10,382 $627,000
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $8,977 - $10,966
-152 Reduced 2.04%
7,282 $436,000
Q2 2019

Aug 07, 2019

BUY
$62.09 - $86.14 $27,319 - $37,901
440 Added 6.29%
7,434 $478,000
Q1 2019

May 14, 2019

SELL
$52.92 - $81.17 $4,074 - $6,250
-77 Reduced 1.09%
6,994 $568,000
Q4 2018

Feb 14, 2019

SELL
$43.37 - $59.54 $2,038 - $2,798
-47 Reduced 0.66%
7,071 $382,000
Q3 2018

Nov 14, 2018

SELL
$42.88 - $53.7 $22,469 - $28,138
-524 Reduced 6.86%
7,118 $367,000
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $23,142 - $28,949
571 Added 8.08%
7,642 $318,000
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $303,358 - $378,854
6,882 Added 3641.27%
7,071 $312,000
Q2 2017

Aug 11, 2017

BUY
N/A
189
189 $10,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.69B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.